Drug distribution models known as white bagging and brown bagging undermine hospitals’ patient safety protections and jeopardize patient care. These practices allow insurers, rather than the patient’s pharmacist and healthcare provider, to determine when, where, and how drugs are purchased, prepared, and administered to patients. Despite patent safety concerns, insurers and pharmacy benefit managers (PBMs) increasingly require hospitals to administer white-bagged and brown-bagged drugs, which they cannot confirm have been stored and prepared safely.
ASHP is Working to:
- Advocate that the Food and Drug Administration enforce safety requirements in the Drug Supply Chain Security Act (DSCSA) undermined by white bagging and brown bagging.
- Encourage state policymakers to prohibit insurers and PBMs from mandating white bagging and brown bagging or from steering patients away from health systems that refuse to accept potentially dangerous white-bagged or brown-bagged drugs.
White Bagging Resources
- ASHP’s Model White Bagging Legislation
- Key Elements of White Bagging Policy
- View White Bagging Infographic
- Five Key Elements of Effective White Bagging Policy
- Letter to FDA - White Bagging and DSCSA pdf
- Model White Bagging Legislation
- ASHP Partners with AHA to Ask FDA to Address White Bagging pdf
- Self-Assessment Tool on White Bagging pdf
- News - White Bagging a Growing Concern for Health Systems